EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) today reported financial results for the three and six months ended June 30, 2007. The Company ended the second quarter with a net loss of $9.6 million, or $0.18 per basic and diluted share on total revenues of $3.1 million compared with net income of $3.2 million, or $0.05 per basic and diluted share on total revenues of $13.9 million for the same period in 2006. The company ended the quarter with $163.7 million in cash and investments.
